International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 4 , Pages 985-986 , 15 July 2009

The Most Important Question

  • Benjamin W. Corn, M.D.

      Affiliations

    • Tel Aviv University School of Medicine, Tel Aviv, Israel
    • Corresponding Author InformationReprint requests to: Benjamin W. Corn, M.D., Tel Aviv University School of Medicine, 6 Weizmann St., Tel Aviv 97261 Israel. Tel: (+972) 2571-4122; Fax: (+972) 2571-3829
    • ,
  • Eli Glatstein, M.D.

      Affiliations

    • University of Pennsylvania School of Medicine, Philadelphia, PA

Received 19 February 2009 ,Revised 12 March 2009 ,Accepted 13 March 2009.

References 

  1. National Cancer Institute. Available from: http://www.cancer.gov. Accessed November 1, 2007.
  2. Dahele M, Pearson S, Pudie T, et al. Practical considerations arising from the implementation of stereotactic body radiation therapy (SBRT) at a comprehensive cancer center. J Thorac Oncol. 2008;3:1332–13412008
  3. Verghese A. Culture shock—Patient as icon, icon as patient. N Engl J Med. 2008;359:2748–2750
  4. Glatstein E, Glick J, Kaiser L, et al. Should randomized clinical trials be required for proton radiotherapy? An alternative view. J Clin Oncol. 2008;26:2438–2439
  5. Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: Systematic review of randomized controlled trials. BMJ. 2003;327:1459–1461

 Conflict of interest: none.

PII: S0360-3016(09)00510-0

doi: 10.1016/j.ijrobp.2009.03.044

International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 4 , Pages 985-986 , 15 July 2009

Article Tools